Sachem Head Capital Management LP Acquires 3,735,000 Shares of Sotera Health Company $SHC

Sachem Head Capital Management LP grew its holdings in shares of Sotera Health Company (NASDAQ:SHC) by 47.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,645,000 shares of the company’s stock after buying an additional 3,735,000 shares during the period. Sotera Health accounts for approximately 4.8% of Sachem Head Capital Management LP’s holdings, making the stock its 11th biggest position. Sachem Head Capital Management LP owned 4.10% of Sotera Health worth $205,418,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. CenterBook Partners LP boosted its holdings in shares of Sotera Health by 94.1% during the 4th quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock valued at $2,673,000 after buying an additional 73,473 shares in the last quarter. Capricorn Fund Managers Ltd bought a new position in Sotera Health in the 4th quarter worth about $7,936,000. Nordea Investment Management AB bought a new position in Sotera Health in the 4th quarter worth about $1,908,000. Exchange Traded Concepts LLC bought a new position in Sotera Health in the 4th quarter worth about $7,739,000. Finally, Retirement Systems of Alabama boosted its stake in Sotera Health by 16.9% in the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock worth $4,391,000 after purchasing an additional 35,974 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

Insider Activity at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the company’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 15.36% of the stock is owned by insiders.

Wall Street Analyst Weigh In

SHC has been the topic of a number of analyst reports. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, April 11th. The Goldman Sachs Group initiated coverage on shares of Sotera Health in a research note on Friday, June 5th. They set a “buy” rating and a $20.00 target price on the stock. Barclays lowered their target price on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Piper Sandler restated an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Finally, Weiss Ratings cut shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, May 21st. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $20.29.

Sotera Health Price Performance

NASDAQ SHC opened at $16.19 on Monday. Sotera Health Company has a 52 week low of $10.80 and a 52 week high of $19.85. The firm has a market capitalization of $4.62 billion, a P/E ratio of 39.49 and a beta of 1.79. The company has a quick ratio of 2.54, a current ratio of 2.82 and a debt-to-equity ratio of 3.56. The company has a 50-day moving average price of $15.61 and a 200-day moving average price of $16.38.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.17 by $0.01. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The firm had revenue of $280.05 million during the quarter, compared to analyst estimates of $270.78 million. During the same quarter in the prior year, the firm earned $0.14 EPS. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Equities research analysts anticipate that Sotera Health Company will post 0.86 earnings per share for the current year.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.